Related Experiment Video

Updated: May 10, 2025

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
09:45

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

Published on: January 29, 2018

9.3K

The multifaceted nature of SUMOylation in heart disease and its therapeutic potential

Ying He1,2, Zhijie Yang1, Dan Guo3

  • 1The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China.

Molecular and Cellular Biochemistry
|April 27, 2025
PubMed

Insights

SUMOylation, a key protein modification, regulates heart function and disease. Understanding SUMOylation mechanisms offers potential new therapeutic targets for heart conditions like hypertrophy and infarction.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cardiovascular Science

Background:

  • SUMOylation (SUMO) is a critical post-translational modification.
  • SUMOylation influences numerous biological processes.
  • It plays a significant role in cardiac function and heart disease.

Purpose of the Study:

  • To review the mechanisms of SUMOylation in cardiac function.
  • To explore SUMOylation's role in various heart diseases.
  • To highlight SUMOylation as a potential therapeutic target.

Main Methods:

  • Literature review of SUMOylation.
  • Analysis of SUMOylation's role in cardiac physiology.
  • Examination of SUMOylation in cardiovascular pathology.

Main Results:

  • SUMOylation impacts cardiac hypertrophy, heart failure, and ischemia-reperfusion injury.
  • SUMOylation is involved in myocardial infarction.
  • Specific SUMOylation pathways are linked to cardiac dysfunction.

Conclusions:

  • SUMOylation is a key regulator of cardiac function and disease.
  • Targeting SUMOylation pathways presents a promising therapeutic strategy for heart disease.
  • Further research into SUMOylation mechanisms is warranted for clinical applications.

Keywords:
Cardiac diseaseCardiac functionSUMOTherapeutic target

More Related Videos

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer08:29

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on: November 1, 2019

7.0K
In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

7.2K

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
401
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.6K